Soho Global Health Tbk PT
IDX:SOHO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
458
765
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Soho Global Health Tbk PT
Soho Global Health Tbk PT
Cash
Soho Global Health Tbk PT
Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Cash
Rp470.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Cash
Rp64.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
23%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Cash
Rp1.6T
|
CAGR 3-Years
-16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Cash
Rp437.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
42%
|
CAGR 10-Years
26%
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Cash
Rp505.4B
|
CAGR 3-Years
129%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
70%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Cash
Rp504.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
Soho Global Health Tbk PT
Glance View
PT SOHO Global Health engages in the provision of healthcare services. The company is headquartered in Jakarta, Dki Jakarta and currently employs 2,373 full-time employees. The company went IPO on 2020-09-08. The firm operates through five segments: Distribution, Professional product, Consumer health, Alliance and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. Its product portfolio ranged from wound care, hospital general care, surgery, orthopedics and in-vitro diagnostics.
See Also
What is Soho Global Health Tbk PT's Cash?
Cash
470.5B
IDR
Based on the financial report for Dec 31, 2023, Soho Global Health Tbk PT's Cash amounts to 470.5B IDR.
What is Soho Global Health Tbk PT's Cash growth rate?
Cash CAGR 5Y
35%
Over the last year, the Cash growth was -9%. The average annual Cash growth rates for Soho Global Health Tbk PT have been 21% over the past three years , 35% over the past five years .
You don't have any saved screeners yet
